TR199902775T2 - 20(S)-Kamptotesin glikokonjugeleri. - Google Patents

20(S)-Kamptotesin glikokonjugeleri.

Info

Publication number
TR199902775T2
TR199902775T2 TR1999/02775T TR9902775T TR199902775T2 TR 199902775 T2 TR199902775 T2 TR 199902775T2 TR 1999/02775 T TR1999/02775 T TR 1999/02775T TR 9902775 T TR9902775 T TR 9902775T TR 199902775 T2 TR199902775 T2 TR 199902775T2
Authority
TR
Turkey
Prior art keywords
camptothecin
glycoconjugeleri
glucoconjugate
oncosis
hydroxylated
Prior art date
Application number
TR1999/02775T
Other languages
English (en)
Inventor
Lerchen Hans-Georg
Von Dem Bruch Karsten
Baumgarten J�Rg
Sperzel Michael
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19801037A external-priority patent/DE19801037A1/de
Priority claimed from DE1998113137 external-priority patent/DE19813137A1/de
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of TR199902775T2 publication Critical patent/TR199902775T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147—Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Electrically Operated Instructional Devices (AREA)

Abstract

Söz konusu bulus 20(S)-kamptotesin glikokonjugeleri ile ilgilidir. Burada 3-0-metilli -L-fukoz birimlerinin 20 hidroksilli kamptotesin türevine tiyoüresi degistirilmis peptit ara halkasi yoluyla baglanan glikokonjuge bilesimlerinin bulusa ait olan yöntem ile hazirlanmalari ve bu bilesimlerinde tedaviye yönelik ilaç olarak bilhassa da onkozlarla baglantili olarak kullanimlari incelenmistir.
TR1999/02775T 1997-05-14 1998-05-04 20(S)-Kamptotesin glikokonjugeleri. TR199902775T2 (tr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19720043 1997-05-14
DE19737477 1997-08-28
DE19801037A DE19801037A1 (de) 1997-05-14 1998-01-14 Glycokonjugate von 20(S)-Camptothecin
DE1998113137 DE19813137A1 (de) 1998-03-25 1998-03-25 Glycokonjugate von 20(S)-Camptothecin

Publications (1)

Publication Number Publication Date
TR199902775T2 true TR199902775T2 (tr) 2000-07-21

Family

ID=27438596

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02775T TR199902775T2 (tr) 1997-05-14 1998-05-04 20(S)-Kamptotesin glikokonjugeleri.

Country Status (19)

Country Link
US (1) US6506734B1 (tr)
EP (1) EP0981542B1 (tr)
JP (1) JP2001526661A (tr)
CN (1) CN1255926A (tr)
AT (1) ATE272648T1 (tr)
AU (1) AU744425B2 (tr)
BG (1) BG103872A (tr)
BR (1) BR9809637A (tr)
CA (1) CA2291436A1 (tr)
HU (1) HUP0003174A3 (tr)
ID (1) ID23424A (tr)
IL (1) IL132534A0 (tr)
NO (1) NO995481L (tr)
NZ (1) NZ500990A (tr)
PL (1) PL336697A1 (tr)
SK (1) SK154899A3 (tr)
TR (1) TR199902775T2 (tr)
TW (1) TW495512B (tr)
WO (1) WO1998051703A1 (tr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19909979A1 (de) * 1999-03-06 2000-09-07 Bayer Ag Verfahren zur Herstellung von Glycokonjugaten von 20(S)-Camptothecin
DE10005275A1 (de) * 2000-02-07 2001-08-09 Bayer Ag Neuartige Glycokonjugate
EP1219634A1 (en) * 2000-12-27 2002-07-03 Bayer Aktiengesellschaft Cytostatic-glycoconjugates having specifically cleavable peptidic linking units
US6350756B1 (en) 2001-01-18 2002-02-26 California Pacific Medical Center Camptothecin derivatives
US6855720B2 (en) 2001-03-01 2005-02-15 California Pacific Medical Center Nitrogen-based camptothecin derivatives
US6403604B1 (en) 2001-03-01 2002-06-11 California Pacific Medical Center Nitrogen-based camptothecin derivatives
EP1238678A1 (en) 2001-03-08 2002-09-11 Bayer Aktiengesellschaft Enzyme-activated cytostatic conjugates with integrin ligands
US6933302B2 (en) 2002-06-03 2005-08-23 California Pacific Medical Center Nitrogen-based homo-camptothecin derivatives
US7875602B2 (en) * 2005-10-21 2011-01-25 Sutter West Bay Hospitals Camptothecin derivatives as chemoradiosensitizing agents
US7766293B2 (en) * 2006-04-25 2010-08-03 Raffel Systems, Llc Lighted cup holder for seating arrangements
WO2014145109A1 (en) 2013-03-15 2014-09-18 Arizona Board Of Regents, For And On Behalf Of, Arizona State University Sugar-linker-drug conjugates
US10046068B2 (en) 2013-03-15 2018-08-14 Arizona Board Of Regents On Behalf Of Arizona State University Saccharide conjugates
CN103333172B (zh) * 2013-06-28 2015-09-30 兰州大学 喜树碱缩氨基硫脲类化合物及其制备方法和用途
CN105566338B (zh) * 2014-10-08 2017-11-21 兰州大学 一种喜树碱类化合物及其制备方法和用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019790A (ja) 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US4943579A (en) 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
US5004758A (en) 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JP2524803B2 (ja) 1988-03-29 1996-08-14 株式会社ヤクルト本社 新規なカンプトテシン誘導体およびその製造法
DK0418099T3 (da) * 1989-09-15 2002-04-02 Res Triangle Inst Fremgangsmåde til fremstilling af 10,11-methylendioxy-20(RS)-camptothecin og 10,11-methylendioxy-20(S)-camptothecinanaloger
US5552154A (en) 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
DE4106101A1 (de) 1991-02-27 1992-09-03 Bayer Ag Fucose-markierte cytostatika
JP3126799B2 (ja) 1992-03-31 2001-01-22 第一製薬株式会社 光学活性カンプトテシン誘導体及びその製法
DE4236237A1 (de) * 1992-10-27 1994-04-28 Behringwerke Ag Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
WO1994019376A1 (fr) * 1993-02-26 1994-09-01 Drug Delivery System Institute, Ltd. Derive de polysaccharide et vehicule de medicament
US6214345B1 (en) * 1993-05-14 2001-04-10 Bristol-Myers Squibb Co. Lysosomal enzyme-cleavable antitumor drug conjugates
GB9320781D0 (en) 1993-10-08 1993-12-01 Erba Carlo Spa Polymer-bound camptothecin derivatives
US5646159A (en) 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
US5646262A (en) * 1994-07-28 1997-07-08 Georgetown University Antisense oligonucleotides against hepatitis B viral replication
US5496830A (en) 1994-09-14 1996-03-05 Johns Hopkins University Inhibition of hemoflagellates by camptothecin compounds
GB9504065D0 (en) * 1995-03-01 1995-04-19 Pharmacia Spa Poly-pyrrolecarboxamidonaphthalenic acid derivatives
DE19512484A1 (de) * 1995-04-04 1996-10-17 Bayer Ag Kohlenhydratmodifizierte Cytostatika
SG50747A1 (en) * 1995-08-02 1998-07-20 Tanabe Seiyaku Co Comptothecin derivatives
CA2192725C (en) * 1995-12-28 2004-04-20 Kenji Tsujihara Camptothecin derivatives
ATE210673T1 (de) * 1996-09-30 2001-12-15 Bayer Ag Glycokonjugate von modifizierten camptothecin- derivaten (20-o-verknüpfung)
DE19640969A1 (de) 1996-10-04 1998-04-16 Bayer Ag 20-0-verknüpfte Glycokonjugate von Camptothecin

Also Published As

Publication number Publication date
TW495512B (en) 2002-07-21
HUP0003174A3 (en) 2003-03-28
AU7761598A (en) 1998-12-08
NO995481D0 (no) 1999-11-09
CA2291436A1 (en) 1998-11-19
EP0981542A1 (de) 2000-03-01
EP0981542B1 (de) 2004-08-04
US6506734B1 (en) 2003-01-14
NO995481L (no) 1999-11-09
IL132534A0 (en) 2001-03-19
BR9809637A (pt) 2000-07-11
ID23424A (id) 2000-04-20
ATE272648T1 (de) 2004-08-15
BG103872A (en) 2000-07-31
AU744425B2 (en) 2002-02-21
WO1998051703A1 (de) 1998-11-19
HUP0003174A2 (hu) 2001-05-28
JP2001526661A (ja) 2001-12-18
CN1255926A (zh) 2000-06-07
NZ500990A (en) 2000-09-29
PL336697A1 (en) 2000-07-03
SK154899A3 (en) 2000-08-14

Similar Documents

Publication Publication Date Title
UA52594C2 (uk) Похідні циклоалканопіридину, суміш їх ізомерів або окремі ізомери, їх солі і n-окиси, спосіб та проміжні сполуки для їх одержання, а також фармацевтична композиція
FI954898A7 (fi) Vesiliukoiset kamptotesiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina
DK1036058T3 (da) Adamantanderivater
DE69808130D1 (de) Adamantan-derivate
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
MX9700885A (es) Nuevas heteroariloxazolidinonas.
TR199700213A2 (tr) 2-Aril sübstitüentli piridinler.
PT740650E (pt) Co-farmacos como um metodo de administracao controlada de farmacos
DE69834923D1 (en) Hochgradig lipophile camptothecin-derivate
PT934329E (pt) Glicoconjugados de derivados de camptotecina modificados (ligacao 20-o)
CA2202531A1 (en) Lyophilizate of lipid complex of water insoluble camptothecins
HUP9900987A3 (en) Camptothecin derivatives process for their preparation, use thereof as antitumor agents and pharmaceutical compositions containing them
ATE272648T1 (de) Glycokonjugate von 20(s)-camptothecin
EE9800145A (et) Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena
FI970740A7 (fi) Funktionaaliset terpyridiini-metallikompleksit, menetelmät niiden valmistamiseksi ja oligonukleotidikonjugaatit terpyridiini-metallikompleksien kanssa
PL308074A1 (en) Derivatives of borone peptides, their production as well as their application in medical therapy
FR2707638B1 (fr) Nouveaux dérivés d'amino-acides, leurs procédés de préparation et leur application thérapeutique.
BG102707A (bg) Нови триазолопурини, метод за тяхното получаване и тяхното приложение като лекарствени средства
EE9800333A (et) Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
ITMI941694A0 (it) Molecole ibride per il trattamento antitumorale loro preparazione e loro uso in composizioni farmaceutiche
BG105326A (bg) Нови бензоилгуанидинови производни с преимуществени свойства, метод за тяхното получаване и тяхнотоприложение при производството на лекарствени средства
FI933506A7 (fi) Bisyklopolyatsamakrosyklokarboksyylihappokomplekseja, niiden konjugaat teja, menetelmä niiden valmistamiseksi ja käyttö varjoaineina
SE9803107D0 (sv) Novel Compunds
KR970006264A (ko) 신규한 6-치환-5, 8-디옥시-1, 4-나프토퀴논 유도체, 그의 제조방법 및 그의 항암제로서의 용도
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate